https://www.thebodypro.com/author/david-alain-wohl

Latest by David Alain Wohl, M.D.

Top 10 HIV Clinical Developments of 2017 Img

Top 10 HIV Clinical Developments of 2017

These major stories changed the way we think about HIV patient care and treatment in 2017. David A. Wohl, M.D., walks us through what happened -- and why it matters.

Heart Attacks in HIV Often Not Due to Atherosclerosis: A Top HIV Clinical Development of 2017 Img
Cardiovascular

Heart Attacks in HIV Often Not Due to Atherosclerosis: A Top HIV Clinical Development of 2017

It is well known that people living with HIV have relatively higher rates of cardiovascular disease (CVD). Whether this increased risk is due to the persistent inflammation caused by HIV, certain HIV medications, someone having more traditional facto...

Bictegravir -- It's Coming: A Top HIV Clinical Development of 2017 Img
News

Bictegravir -- It's Coming: A Top HIV Clinical Development of 2017

Last year's antiretroviral darling was dolutegravir (Tivicay, DTG). Now, the limelight has shifted to its integrase sibling, bictegravir. Requiring no pharmacological boosting, boasting a high barrier to resistance, and in early 2018 available co-for...

ART Resistance Spreads: A Top HIV Clinical Development of 2017 Img
News

ART Resistance Spreads: A Top HIV Clinical Development of 2017

With expansion of the use of antimicrobial agents comes the inevitable expansion of microbial drug resistance -- and so it is with antiretrovirals. In a 2017 World Health Organization (WHO) report on surveillance for pre-treatment antiretroviral drug...

Switch Frenzy: A Top HIV Clinical Development of 2016 Img

Switch Frenzy: A Top HIV Clinical Development of 2016

Top 10 Clinical Developments of 20161. Donald Trump6. Return of the Antibodies2. Switch Frenzy7. Is an Unexpected Low HIV RNA Level Real?3. 2-Drug ART8. Dolutegravir and the Central Nervous System4. Is HIV PrEP at a Tipping Point?9. TAF in Hepatitis ...

Donald Trump: A Top HIV Clinical Development of 2016 Img

Donald Trump: A Top HIV Clinical Development of 2016

Top 10 Clinical Developments of 20161. Donald Trump6. Return of the Antibodies2. Switch Frenzy7. Is an Unexpected Low HIV RNA Level Real?3. 2-Drug ART8. Dolutegravir and the Central Nervous System4. Is HIV PrEP at a Tipping Point?9. TAF in Hepatitis ...

Start ART Now: A Top HIV Clinical Development of 2016 Img

Start ART Now: A Top HIV Clinical Development of 2016

Top 10 Clinical Developments of 20161. Donald Trump6. Return of the Antibodies2. Switch Frenzy7. Is an Unexpected Low HIV RNA Level Real?3. 2-Drug ART8. Dolutegravir and the Central Nervous System4. Is HIV PrEP at a Tipping Point?9. TAF in Hepatitis ...

Blip or Bloop: Is an Unexpected Low HIV RNA Level Real?: A Top HIV Clinical Development of 2016 Img

Blip or Bloop: Is an Unexpected Low HIV RNA Level Real?: A Top HIV Clinical Development of 2016

Top 10 Clinical Developments of 20161. Donald Trump6. Return of the Antibodies2. Switch Frenzy7. Is an Unexpected Low HIV RNA Level Real?3. 2-Drug ART8. Dolutegravir and the Central Nervous System4. Is HIV PrEP at a Tipping Point?9. TAF in Hepatitis ...

Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016 Img

Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016

Top 10 Clinical Developments of 20161. Donald Trump6. Return of the Antibodies2. Switch Frenzy7. Is an Unexpected Low HIV RNA Level Real?3. 2-Drug ART8. Dolutegravir and the Central Nervous System4. Is HIV PrEP at a Tipping Point?9. TAF in Hepatitis ...

New HIV Infections in U.S. Are Down -- a Bit: A Top HIV Clinical Development of 2016 Img

New HIV Infections in U.S. Are Down -- a Bit: A Top HIV Clinical Development of 2016

Top 10 Clinical Developments of 20161. Donald Trump6. Return of the Antibodies2. Switch Frenzy7. Is an Unexpected Low HIV RNA Level Real?3. 2-Drug ART8. Dolutegravir and the Central Nervous System4. Is HIV PrEP at a Tipping Point?9. TAF in Hepatitis ...